Published in Biochimie on May 01, 2005
Evidence of purifying selection on merozoite surface protein 8 (MSP8) and 10 (MSP10) in Plasmodium spp. Infect Genet Evol (2012) 1.01
Isolation, production and characterization of fully human monoclonal antibodies directed to Plasmodium falciparum MSP10. Malar J (2015) 0.86
Comparative proteomic analysis of metabolically labelled proteins from Plasmodium falciparum isolates with different adhesion properties. Malar J (2006) 0.84
Plasmodium falciparum merozoite surface protein 3: oligomerization, self-assembly, and heme complex formation. J Biol Chem (2013) 0.81
Developmental biology of sporozoite-host interactions in Plasmodium falciparum malaria: implications for vaccine design. Clin Microbiol Rev (2006) 0.81
Identifying putative Mycobacterium tuberculosis Rv2004c protein sequences that bind specifically to U937 macrophages and A549 epithelial cells. Protein Sci (2005) 0.80
HIV Malaria Co-Infection Is Associated with Atypical Memory B Cell Expansion and a Reduced Antibody Response to a Broad Array of Plasmodium falciparum Antigens in Rwandan Adults. PLoS One (2015) 0.76
Characterization of Plasmodium falciparum integral membrane protein Pf25-IMP and identification of its red blood cell binding sequences inhibiting merozoite invasion in vitro. Protein Sci (2008) 0.75
[Influence of shear stress on in-stent restenosis: in vivo study using 3D reconstruction and computational fluid dynamics]. Rev Esp Cardiol (2006) 1.55
Liver stage antigen 3 Plasmodium falciparum peptides specifically interacting with HepG2 cells. J Mol Med (Berl) (2004) 1.46
Pathogenic perspectives for the role of inflammation in diabetic nephropathy. Clin Sci (Lond) (2009) 1.37
Renal pro-inflammatory cytokine gene expression in diabetic nephropathy: effect of angiotensin-converting enzyme inhibition and pentoxifylline administration. Am J Nephrol (2006) 1.29
Tachycardia-related channel in the scar tissue in patients with sustained monomorphic ventricular tachycardias: influence of the voltage scar definition. Circulation (2004) 1.27
Synthetic aperture superresolution with multiple off-axis holograms. J Opt Soc Am A Opt Image Sci Vis (2006) 1.11
Tumor necrosis factor-alpha as a therapeutic target for diabetic nephropathy. Cytokine Growth Factor Rev (2009) 1.10
Tumor necrosis factor-alpha gene expression in diabetic nephropathy: relationship with urinary albumin excretion and effect of angiotensin-converting enzyme inhibition. Kidney Int Suppl (2005) 1.09
Superresolution digital holographic microscopy for three-dimensional samples. Opt Express (2008) 1.08
Urinary tumour necrosis factor-alpha excretion independently correlates with clinical markers of glomerular and tubulointerstitial injury in type 2 diabetic patients. Nephrol Dial Transplant (2006) 1.07
Intimate molecular interactions of P. falciparum merozoite proteins involved in invasion of red blood cells and their implications for vaccine design. Chem Rev (2008) 1.06
Additive antiproteinuric effect of pentoxifylline in patients with type 2 diabetes under angiotensin II receptor blockade: a short-term, randomized, controlled trial. J Am Soc Nephrol (2005) 1.03
Synthetic aperture superresolved microscopy in digital lensless Fourier holography by time and angular multiplexing of the object information. Appl Opt (2010) 1.03
Plasmodium vivax promiscuous T-helper epitopes defined and evaluated as linear peptide chimera immunogens. Infect Immun (2002) 1.00
Changes in morphology and ionic transport induced by ALD SiO₂ coating of nanoporous alumina membranes. ACS Appl Mater Interfaces (2013) 0.98
Hepatitis C virus (HCV) E1 and E2 protein regions that specifically bind to HepG2 cells. J Hepatol (2002) 0.95
Mineral metabolism and inflammation in chronic kidney disease patients: a cross-sectional study. Clin J Am Soc Nephrol (2009) 0.94
Immunological profile of a Plasmodium vivax AMA-1 N-terminus peptide-carbon nanotube conjugate in an infected Plasmodium berghei mouse model. Vaccine (2008) 0.94
Plasmodium vivax merozoite surface protein 8 cloning, expression, and characterisation. Biochem Biophys Res Commun (2004) 0.94
Plasmodium vivax MSP-1 peptides have high specific binding activity to human reticulocytes. Vaccine (2002) 0.94
Toxoplasma gondii: immunogenicity and protection by P30 peptides in a murine model. Exp Parasitol (2006) 0.92
Identifying Plasmodium falciparum merozoite surface antigen 3 (MSP3) protein peptides that bind specifically to erythrocytes and inhibit merozoite invasion. Protein Sci (2005) 0.92
Influence of renal involvement on peripheral blood mononuclear cell expression behaviour of tumour necrosis factor-alpha and interleukin-6 in type 2 diabetic patients. Nephrol Dial Transplant (2007) 0.91
Distribution patterns of infection with multiple types of human papillomaviruses and their association with risk factors. PLoS One (2011) 0.91
Identification of conserved erythrocyte binding regions in members of the Plasmodium falciparum Cys6 lipid raft-associated protein family. Vaccine (2009) 0.91
Computational prediction and experimental assessment of secreted/surface proteins from Mycobacterium tuberculosis H37Rv. PLoS Comput Biol (2010) 0.91
Abnormal levels of circulating endothelial progenitor cells during exacerbations of COPD. Lung (2010) 0.90
Superresolution optical system by common-path interferometry. Opt Express (2006) 0.89
Effects of Consecutive Basketball Games on the Game-Related Statistics that Discriminate Winner and Losing Teams. J Sports Sci Med (2009) 0.88
Identification of PMF1 methylation in association with bladder cancer progression. Clin Cancer Res (2008) 0.88
Randomized prospective comparison between erythropoietin and androgens in CAPD patients. Kidney Int (2002) 0.88
Quantitative structure-activity relationships of mosquito larvicidal chalcone derivatives. J Agric Food Chem (2012) 0.88
Specific erythrocyte binding capacity and biological activity of Plasmodium falciparum erythrocyte binding ligand 1 (EBL-1)-derived peptides. Protein Sci (2005) 0.88
Plasmodium falciparum TryThrA antigen synthetic peptides block in vitro merozoite invasion to erythrocytes. Biochem Biophys Res Commun (2005) 0.87
PvRON2, a new Plasmodium vivax rhoptry neck antigen. Malar J (2011) 0.87
Detection by PCR of human papillomavirus in Colombia: Comparison of GP5+/6+ and MY09/11 primer sets. J Virol Methods (2011) 0.87
Gamma-irradiation effects on biopharmaceutical properties of PLGA microspheres loaded with SPf66 synthetic vaccine. Eur J Pharm Biopharm (2007) 0.86
Identifying and characterising the Plasmodium falciparum RhopH3 Plasmodium vivax homologue. Biochem Biophys Res Commun (2007) 0.86
Identification and characterisation of the Plasmodium vivax rhoptry-associated protein 2. Biochem Biophys Res Commun (2005) 0.86
Cloning, expression, and characterisation of a Plasmodium vivax MSP7 family merozoite surface protein. Biochem Biophys Res Commun (2006) 0.85
Sporozoite and liver stage antigen Plasmodium falciparum peptides bind specifically to human hepatocytes. Vaccine (2004) 0.85
The Plasmodium vivax rhoptry-associated protein 1. Biochem Biophys Res Commun (2006) 0.85
Validating subcellular localization prediction tools with mycobacterial proteins. BMC Bioinformatics (2009) 0.84
Plasmodium vivax Duffy binding protein peptides specifically bind to reticulocytes. Peptides (2002) 0.84
MAEBL Plasmodium falciparum protein peptides bind specifically to erythrocytes and inhibit in vitro merozoite invasion. Biochem Biophys Res Commun (2004) 0.84
Electroplating and magnetostructural characterization of multisegmented Co54Ni46/Co85Ni15 nanowires from single electrochemical bath in anodic alumina templates. Nanoscale Res Lett (2013) 0.84
Quantitative phase microscopy using defocusing by means of a spatial light modulator. Opt Express (2010) 0.84
Conserved high activity binding peptides are involved in adhesion of two detergent-resistant membrane-associated merozoite proteins to red blood cells during invasion. J Med Chem (2010) 0.84
Structure, Immunogenicity, and Protectivity Relationship for the 1585 Malarial Peptide and Its Substitution Analogues. Angew Chem Int Ed Engl (2001) 0.83
Treatment of patients with in-stent restenosis. EuroIntervention (2009) 0.83
Mycobacterium tuberculosis Rv0679c protein sequences involved in host-cell infection: potential TB vaccine candidate antigen. BMC Microbiol (2010) 0.83
Identifying Plasmodium falciparum cytoadherence-linked asexual protein 3 (CLAG 3) sequences that specifically bind to C32 cells and erythrocytes. Protein Sci (2005) 0.83
Identification and polymorphism of Plasmodium vivax RBP-1 peptides which bind specifically to reticulocytes. Peptides (2002) 0.83
Peptides from the Plasmodium falciparum STEVOR putative protein bind with high affinity to normal human red blood cells. Peptides (2005) 0.83
Studies of Plasmodium falciparum rhoptry-associated membrane antigen (RAMA) protein peptides specifically binding to human RBC. Vaccine (2007) 0.83
Identifying and characterising the Plasmodium falciparum merozoite surface protein 10 Plasmodium vivax homologue. Biochem Biophys Res Commun (2005) 0.83